BSVN.NASDAQBank7 CORP

Form 4: Bank7 Corp. Executive Sells Over 3,300 Shares Under Pre-Arranged Plan

Sentiment:

Insider Transaction Report


Bank7 Corp.'s Executive Vice President and Chief Compliance Officer, Jason E. Estes, sold 3,332 shares of common stock in multiple transactions in late July 2025.

Worse than expectedExecutive Jason E. Estes sold 3,332 shares of common stock, which, despite being pre-planned, reduces insider ownership and can be perceived as a negative signal by investors.

Summary

  • Jason E. Estes, Executive Vice President and Chief Compliance Officer of Bank7 Corp. (BSVN), reported the sale of 3,332 shares of common stock.
  • The sales occurred over three days: 1 share at $49.00 and 818 shares at $49.05 on July 22, 2025; 634 shares at $48.50 on July 23, 2025; and 1,587 shares at $47.50 and 292 shares at $48.00 on July 24, 2025.
  • Following these transactions, Jason E. Estes beneficially owns 75,961 shares of Bank7 Corp. common stock.
  • The reported transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
  • Beneficial ownership includes various restricted stock units (RSUs): 6,052 RSUs vesting in three equal installments on February 15, 2026, 2027, and 2028; 1,875 RSUs (from an original grant of 7,500) vesting in four equal installments on December 17, 2022, 2023, 2024, and 2025; 5,098 RSUs (from an original grant of 7,647) vesting in three equal installments on February 15, 2025, 2026, and 2027; and 2,936 RSUs (from an original grant of 8,808) vesting in three equal installments on February 15, 2024, 2025, and 2026.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider selling, although the impact is mitigated by the fact that the sales were conducted under a pre-arranged Rule 10b5-1 plan, suggesting they were not based on new, adverse information.

Positives

  • The stock sales were conducted under a Rule 10b5-1(c) plan, which indicates the transactions were pre-scheduled and not based on new, non-public information, mitigating concerns about insider sentiment.

Negatives

  • Insider selling, even if pre-arranged, can be perceived by the market as a reduction in an executive's direct stake and may be interpreted as a slightly negative signal regarding future prospects or valuation.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on the insider's stock transactions.

Industry Context

This filing represents a routine insider transaction for an executive at a financial institution. Such sales are common for compensation management or personal financial planning, especially when conducted under a Rule 10b5-1 plan, which is a standard practice in the banking and broader corporate sector to manage insider trading compliance.

Stakeholder Impact

  • Shareholders may interpret the executive's sale of shares as a decrease in confidence or a move to diversify personal holdings, potentially leading to negative sentiment, although the Rule 10b5-1 plan helps to alleviate concerns about opportunistic selling.

Next Steps

  • Future vesting of restricted stock units for Jason E. Estes on various dates through February 15, 2028.

Key Dates

DateDescription
2022-12-17First vesting installment for a grant of 7,500 restricted stock units.
2023-12-17Second vesting installment for a grant of 7,500 restricted stock units.
2024-02-15First vesting installment for a grant of 8,808 restricted stock units.
2024-12-17Third vesting installment for a grant of 7,500 restricted stock units.
2025-02-15First vesting installment for a grant of 7,647 restricted stock units and second vesting installment for a grant of 8,808 restricted stock units.
2025-07-22Transaction date for the sale of 1 share at $49.00 and 818 shares at $49.05.
2025-07-23Transaction date for the sale of 634 shares at $48.50.
2025-07-24Transaction date for the sale of 1,587 shares at $47.50 and 292 shares at $48.00. Also the filing date of the Form 4.
2025-12-17Fourth and final vesting installment for a grant of 7,500 restricted stock units.
2026-02-15First vesting installment for a grant of 6,052 restricted stock units, second vesting installment for a grant of 7,647 restricted stock units, and third and final vesting installment for a grant of 8,808 restricted stock units.
2027-02-15Second vesting installment for a grant of 6,052 restricted stock units and third and final vesting installment for a grant of 7,647 restricted stock units.
2028-02-15Third and final vesting installment for a grant of 6,052 restricted stock units.

Recommendation

hold

The Executive Vice President and CCO of Bank7 Corp. sold a significant number of shares. While these sales were conducted under a pre-arranged Rule 10b5-1 plan, which suggests they are not based on new negative information, insider selling can still be perceived by the market as a reduction in management's direct stake and confidence. Without additional financial or strategic updates, this transaction alone suggests a 'hold' position, as it's a routine, albeit large, insider sale.

Keywords

Bank7 Corp, BSVN, Jason E. Estes, insider trading, stock sale, SEC Form 4, executive compensation, restricted stock units, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.